UROLOGIX, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0001 USD | +9,900.00% |
|
-.--% | -.--% |
| 2016 | A unknown buyer acquired substantially all of the operating assets of Urologix, Inc. | CI |
| 2015 | Urologix Conducting A Strategic Review | CI |
Financials (USD)
| Sales 2013 | 16.48M | Sales 2014 | 14.01M | Capitalization | 3.66M |
|---|---|---|---|---|---|
| Net income 2013 | -4M | Net income 2014 | -7M | EV / Sales 2013 | 0.4 x |
| Net Debt 2013 | 3.04M | Net Debt 2014 | 4.62M | EV / Sales 2014 | 0.59 x |
| P/E ratio 2013 |
-0.8
x | P/E ratio 2014 |
-0.49
x | Employees | 61 |
| Yield 2013 * |
-
| Yield 2014 |
-
| Free-Float | 100% |
More Fundamentals
* Assessed data
More news
| 1 day | +9,900.00% |
Current year
0.00
0.00
1 year
0.000.00
3 years
0.000.02
5 years
0.000.02
10 years
0.000.20
| Managers | Title | Age | Since |
|---|---|---|---|
Mitchell Dann
FOU | Founder | 63 | 91-05-28 |
Scott Madson
DFI | Director of Finance/CFO | 63 | 15-03-31 |
Lisa Ackermann
SAM | Sales & Marketing | 51 | 11-06-15 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Mitchell Dann
FOU | Founder | 63 | 91-05-28 |
Sidney Emery
BRD | Director/Board Member | 74 | 05-09-30 |
| Director/Board Member | 57 | 10-08-05 |
21st North Inc. is not engaged in any operating activity. The Company has dissolved.
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 2.13K | |
| +8.07% | 219B | |
| +6.59% | 183B | |
| +11.26% | 133B | |
| +26.57% | 108B | |
| +0.65% | 63.06B | |
| +13.35% | 52.02B | |
| -0.62% | 48.2B | |
| -0.93% | 40.37B | |
| +11.54% | 39.35B |
- Stock Market
- Equities
- ULGX Stock
